Taiyen Biotech Co., Ltd. (1737)
TWSE
30.00
0.00 (0.00%)
Closed
Oct 2, 2026
Day's Range
30.0030.10
52 wk Range
29.3033.00
Financial Statements - 1737 - Taiyen Biotech Co., Ltd.
Revenue
3.30B▲ 2.1%
Net Income
393.68M▲ 24.0%Net Margin 11.9%
EBITDA
733.60M▼ 0.1%
Free Cash Flow
130.25M▼ 63.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.30B | 3.23B | 3.40B | 3.61B | 4.09B | 3.13B |
| Cost of Goods | 1.96B | 1.91B | 2.15B | 2.33B | 2.72B | 1.82B |
| Gross Profit | 1.34B | 1.32B | 1.25B | 1.27B | 1.37B | 1.30B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 466.47M | 430.80M | 395M | 445.05M | 529.17M | 463.32M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 493.96M | 433.03M | 329.11M | 530.58M | 509.91M | 464.03M |
| Income Tax | 100.28M | 115.58M | 111.82M | 103.07M | 97.75M | 89.45M |
| Net Income | 393.68M | 317.45M | 217.29M | 427.51M | 412.16M | 374.58M |
| EPS Basic | 2 | 1.86 | 1.5 | 2.13 | 1.97 | 1.83 |
| EPS Diluted | 1.99 | 1.85 | 1.5 | 2.13 | 1.96 | 1.82 |
| Basic Shares Outstanding | 200M | 200M | 200M | 200M | 200M | 200M |
| Diluted Shares Outstanding | 200M | 200M | 200M | 200M | 200M | 200M |
| Ebit | 497.34M | 439.37M | 332.46M | 535.11M | 515.86M | 467.64M |
| Ebitda | 733.60M | 734.23M | 612.09M | 730.05M | 705.52M | 653.65M |
| Net Income Continuous Operations | 493.96M | 433.03M | 329.11M | 530.58M | 509.91M | 464.03M |
| Minority Interests | 6.18M | 54.07M | 83.09M | -812K | -18.93M | -9.50M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
